ViVac announced the appointment of Keren Leshem as Chief Executive Officer, marking a significant milestone in the company’s evolution from research-driven startup to emerging leader in RNA-based cancer immunotherapy. Leshem, a World Economic Forum Technology Pioneer CEO , has been recognized by Forbes and Entrepreneur as one of the most influential voices in biotechnology. She brings over two decades of experience building and scaling clinical-stage life science companies